Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 11, Novembre 2010
Page(s) 943 - 949
Section Resistance aux antibiotiques : un enjeu international
DOI https://doi.org/10.1051/medsci/20102611943
Publié en ligne 15 novembre 2010
  1. Oliveira DC, Tomasz A, Lencastre H. Secrets of success of a human pathogen : molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002 ; 2 : 180-9.
  2. Kuroda M, Ohta T, Uchiyama I, et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001 ; 357 : 1225-40.
  3. Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillinresistant Staphylococcus aureus as a community pathogen. Diagn Microbiol Infect Dis 2001 ; 40 : 1-4.
  4. Ito T, Okuma K, Ma XX, et al. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome : genomic island SCC. Drug Resist Updat 2003 ; 6 : 41-52.
  5. Hiramatsu K, Cui L, Kuroda M, et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001 ; 9 : 486-93.
  6. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000 ; 44 : 1549-55.
  7. Ito T, Ma XX, Takeuchi F, et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004 ; 48 : 2637-51.
  8. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002 ; 46 : 2155-61.
  9. International working group on the classification of staphylococcal cassette chromosome elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec) : guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother 2009 ; 53 : 4961-7.
  10. Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009 ; 53 : 531-40.
  11. Hiramatsu K, Katayama Y, Yuzawa H, et al. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol 2002 ; 292 : 67-74.
  12. Katayama Y, Takeuchi F, Ito T, et al. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J Bacteriol 2003 ; 185 : 2711-22.
  13. Tsubakishita S, Kuwahara-Arai K, Baba T, et al. Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus. Antimicrob Agents Chemother 2010 ; 54 : 1469-75.
  14. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France : emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002 ; 35 : 819-24.
  15. Woodin AM. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 1960 ; 75 : 158-65.
  16. Konig B, Prevost G, Piemont Y, et al. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1995 ; 171 : 607-13.
  17. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002 ; 359 : 753-9.
  18. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes : worldwide emergence. Emerg Infect Dis 2003 ; 9 : 978-84.
  19. Dauwalder O, Lina G, Durand G, et al. Epidemiology of invasive methicillinresistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008 ; 46 : 3454-8.
  20. Durand G, Bes M, Meugnier H, et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital and community-acquired infections in France. J Clin Microbiol 2006 ; 44 : 847-53.
  21. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997 ; 350 : 1670-3.
  22. Sancak B, Ercis S, Menemenlioglu D, et al. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005 ; 56 : 519-23.
  23. Wootton M, Howe RA, Hillman R, et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001 ; 47 : 399-403.
  24. Cui L, Iwamoto A, Lian JQ, et al. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006 ; 50 : 428-38.
  25. Swenson JM, Anderson KF, Lonsway DR, et al. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2009 ; 47 : 2013-7.
  26. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007 ; 60 : 788-94.
  27. Ho PL, Lo PY, Chow KH, et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 2010 ; 60 : 140-5.
  28. Gould IM. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008 ; 31 (suppl 2) : 1-9.
  29. Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004 ; 42 : 2398-402.
  30. Maclayton DO, Suda KJ, Coval KA, et al. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 2006 ; 28 : 1208-16.
  31. Soriano A, Marco F, Martinez JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2008 ; 46 : 193-200.
  32. Vandenesh F, Lina G, Gillet Y et al. Chronique d’une controverse sur une bactérie équipée pour tuer. Med Sci (Paris) 2009 ; 25 : 984-6.
  33. Cattoir V, Leclercq R. Les entérocoques résistants aux glycopeptides. Med Sci (Paris) 2010 ; 26 : 936-42.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.